Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2154

Journal of Biotechnology & Biomaterials received 2154 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Recommended Journals
Share This Page

Evaluation of the antineoplastic potential of new natural compounds in glioblastoma lines

2nd World Biotechnology Congress

Lorena R Sousa, Ana G Silva, Vanessa G P Severino, Joao G M Junqueira, Renato J S Oliveira, Rui M V Reis and Rosy I M A Ribeiro

UFSJ, Brazil UFG, Brazil CPOM-Barretos, Brazil

ScientificTracks Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X-C1-085

Abstract
Nowadays, cancer is one of the diseases with the highest number of deaths worldwide. Glioblastomas are one of the most aggressive tumors of the central nervous system in adults. The average survival rate of patients diagnosed with this disease is only 3% in five years. The available treatments are only palliative, justifying the need of studies aimed at screening new compounds more effective for clinical use. The present study aimed to evaluate the antitumor potential of plant extracts of Annona coreacea in two human glioma lines, GAMG and U251. Cell viability was quantified by the reduction of MTT ([3-(4,5-dimethylthiazol-2yl)-2,5diphenyltetrazolium bromide) to formazan, its metabolization being proportional to the number of viable cells. The absorbance was measured by the spectrophotometer at wavelength 570 nm after 2 hours and 30 minutes incubation with MTT (2.5 mg/mL). The IC50 of all compounds was elucidated by a 24 hours dilution curve with concentrations (1 �?�?�?µg/mL, 7 �?�?�?µg/mL, 15 �?�?�?µg/mL and 25 �?�?�?µg/ mL). AcL3 was the most promising partition for U251, with IC50 equal to 1.355�?�?�?µg/mL, and for GAMG AcL1 partition shown the best result, IC50 equal to 3.355 �?�?�?µg/mL. Migration assay was performed using the "wound-healing" methodology and aimed to evaluate the potential inhibition on cell migration of the partitions against U251 cell lines. Cells were treated with the IC50, pre-determined by MTT assay. Relative migration was estimated by the formula: % wound-healing percentage: (%) = 100 (AB)/A, where A is the width of the wounds before treatment, and B is the width of the wounds after treatment. The images were obtained at times 0, 12, 24 and 72 hours after treatment for measurements. AcL3 and AcL4 shown to be the best compounds when analyzed the inhibitory potential of the extracts on cell migration.
Biography

Lorena R Sousa has formed in Biology in 2015 at University Federal of Pampa located in SG, RS. Currently, she is pursuing her MS in Biochemistry and Molecular Biology at University Federal of São Joao Del Rey located in Divinopolis, MG. She works with glioblastomas cell lines, an aggressive tumor of the nervous central system of adults. In past, she worked with some other diseases such as Alzheimer's and Parkinson, using Drosophila melanogaster as an alternative model organism.
 

Top